Cancer pharmacogenetics
Open Access
- 6 January 2004
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 90 (1) , 8-11
- https://doi.org/10.1038/sj.bjc.6601487
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Pharmacogenomics — Drug Disposition, Drug Targets, and Side EffectsNew England Journal of Medicine, 2003
- SNP databases and pharmacogenetics: great start, but a long way to goHuman Mutation, 2002
- The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomicsPharmacogenomics, 2002
- UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicityThe Pharmacogenomics Journal, 2002
- Thymidylate Synthase Pharmacogenetics in Colorectal CancerClinical Colorectal Cancer, 2001
- Methods for Genotyping Single Nucleotide PolymorphismsAnnual Review of Genomics and Human Genetics, 2001
- A map of human genome sequence variation containing 1.42 million single nucleotide polymorphismsNature, 2001
- Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distributionCarcinogenesis: Integrative Cancer Research, 1998
- Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.Journal of Clinical Investigation, 1996
- Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.Cell Structure and Function, 1995